March 2021 – Community Voices 340B

Op-ed by Prominent Community Leaders Highlights Severe Damage of New York’s Proposed Medicaid Carve-out

On March 23, an op-ed written by three prominent community leaders, Ms. Hazel Dukes, Rev Kirsten John Foy, and Rev Dr. Johnnie Green, was published in

Webinar: The Impact of Women in the 340B Drug Pricing Program

In this webinar sponsored by CV-340B, our panel of four exceptional leaders at the forefront of 340B will discuss the impact of women in 340B. The speakers

Bipartisan Group of Senators Reintroduce Bill to Protect Eligibility of 340B Hospitals During COVID-19 Pandemic

Last week, a bipartisan group of six senators, led by Senator John Thune (R-SD), reintroduced legislation (S. 773) that would allow disproportionate share

Indiana District Court Issues Order to Halt the 340B Administrative Dispute Resolution for Claims Against to Eli Lilly

On March 16, 2021, the U.S. District Court for the Southern District of Indiana issued an order granting Eli Lilly’s request for a preliminary injunction

HHS issues proposal to further delay the Trump Administration’s 340B insulin final rule

On March 9, 2021 the Department of Health and Human Services (HHS) issued a proposal to further delay implementation of the Trump Administration’s final

Express Scripts Issues 340B Claims Identification Requirements

Express Scripts, a large US-based PBM, announced a new 340B retrospective claims identification requirement. The new policy may impose significant burdens

PRESS STATEMENT: CV340B Names Advisory Council

March 2, 2021 PRESS STATEMENT: FOR IMMEDIATE RELEASE Contact: Peggy.Tighe@PowersLaw.com CV340B Names Advisory

226 Members of Congress Sign Letter Condemning Manufacturer Actions

In a letter, led by Representatives Spanberger, Axne, Matsui, McKinley, sent to Acting HHS Secretary Norris Cochran, 226 Members of Congress called on HHS

Month: March 2021